XML 21 R6.htm IDEA: XBRL DOCUMENT v2.3.0.15
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) (USD $)
9 Months Ended165 Months Ended
Sep. 30, 2011
Sep. 30, 2010
Sep. 30, 2011
Net Loss$ (7,511,015)$ (6,583,448)$ (65,943,935)
Write off of intangible assets  505,000
Settlement of litigation and debt(114,903) (1,277,223)
Settlement of debt due Morale/Matthews  927,903
Stock based compensation expense919,289206,2634,854,445
Issuance of common stock for services862,000713,6378,034,788
Issuance of options for legal settlement  31,500
Issuance of warrants for legal settlement  4,957
Issuance of warrants for financing fees  153,501
Issuance of warrants for consulting fees339,122126,000465,122
Increase in convertible notes related to default2,37635,313298,855
Interest on related party loans  22,305
Patent acquisition cost  1,610,066
Amortization of issuance costs and original issue debt discounts including beneficial conversion feature-part of interest expense4,796,6473,179,79915,861,278
Fair value of common stock and warrants issued to induce conversion of notes 168,340469,043
Costs of private placement convertible notes 1,129,2121,640,715
Change in fair value of derivative liability(2,722,084)(1,300,845)(2,828,749)
Amortization of deferred compensation  3,060,744
Loss on disposition of assets  14,426
Depreciation and amortization of leasehold improvements25,73525,844485,917
Bad debt  1,300
Accounts receivable  (1,380)
Inventory000
Prepaid expenses and other(28,908)(16,854)(58,253)
Other assets(2,310) (10,330)
Accounts payable and accrued expenses154,22034,3344,766,551
Accounts payable – license agreements(375,172)(146,723)(369,887)
Accounts payable – related parties(167,788)37,477(19,615)
Net cash used in operating activities(3,822,791)(2,391,651)(27,300,956)
Purchase of equipment(32,243)(11,235)(598,862)
Proceeds from sale of equipment  17,478
Net cash used in investing activities(32,243)(11,235)(581,384)
Net proceeds under equity line of credit  1,262,386
(Decrease) increase in payables to related parties and stockholder(86,947)(11,865)536,979
Advances from founding executive officer  517,208
Net proceeds from issuance of convertible notes and warrants3,831,4302,390,37615,036,408
Repayment of convertible notes  (282,121)
Proceeds from sale of stock and exercise of warrants and options13,50015,30010,816,074
Net cash provided by financing activities3,757,9832,393,81127,886,934
Net increase in cash(97,051)(9,075)4,594
Cash, beginning of period101,64533,611 
Cash, end of period4,59424,5364,594
Interest11,71316,485171,079
Income taxes8008007,482
Acquisition of intangible asset through advance from related party and issuance of common stock  505,000
Deferred compensation for stock options issued for services862,000 3,202,931
Purchase of property and equipment financed by advance from related party  3,550
Conversion of related party debt to equity  515,000
Issuance of common stock in settlement of payable 4,121247,584
Cancellation of stock  8,047
Conversion of accounts payable and accrued expenses to common stock  612,521
Conversion of accounts payable and accrued expenses to convertible debentures301,075281,199632,275
Conversion of related party debt to convertible debentures 22,50072,500
Conversion of convertible debentures to common stock4,702,3863,643,25315,488,367
Issuance of shares for settlement of loans and other payables  2,783,711
Write off of deferred compensation  142,187
Fair value of derivative liability recorded as note discount 1,243,6252,130,625
Proceeds of exercise of options applied to accounts payable7,50030,00067,500
Fair value of warrants and beneficial conversion feature associated with issued convertible notes$ 4,132,505$ 1,450,450$ 12,378,893